Rate of increase in circulating IL-7 and loss of IL-7Rα expression differ in HIV-1 and HIV-2 infections: Two lymphopenic diseases with similar hyperimmune activation but distinct outcomes

Journal of Immunology

Volumn 178, Issue 5, 2007, Pages 3252-3259

  Albuquerque, Adriana S ^a   Cortesão, Catarina S ^a   Foxall, Russell B ^a   Soares, Rui S ^a   Victorino, Rui M M ^a   Sousa, Ana E ^a,b  

^a UNIVERSITY OF LISBON   (Portugal)

^b INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 7; INTERLEUKIN 7 RECEPTOR ALPHA;

ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; EFFECTOR CELL; FEMALE; HOMEOSTASIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS 2 INFECTION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; MALE; PERSISTENT INFECTION; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL; T LYMPHOCYTE;

EID: 33847376547     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.5.3252     Document Type: Article

References (59)

1. Fry, T. J., E. Connick, J. Falloon, M. M. Lederman, D. J. Liewehr, J. Spritzler, S. M. Steinberg, L. V. Wood, R. Yarchoan, J. Zuckerman, et al. 2001. A potential role for interleukin-7 in T-cell homeostasis. Blood 97: 2983-2990.
2. Fry, T. J., and C. L. Mackall. 2001. Interleukin-7: master regulator of peripheral T-cell homeostasis? Trends Immunol. 22: 564-571.
3. Schluns, K. S., W. C. Kieper, S. C. Jameson, and L. Lefrancois. 2000. Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo. Nat. Immunol. 1: 426-432.
4. Kondrack, R. M., J. Harbertson, J. T. Tan, M. E. McBreen, C. D. Surh, and L. M. Bradley. 2003. Interleukin 7 regulates the survival and generation of memory CD4 cells. J. Exp. Med. 198: 1797-1806.
5. + T-regulatory cells. J. Immunother. 29: 313-319.
6. Beq, S., M. T. Nugeyre, R. Ho Tsong Fang, D. Gautier, R. Legrand, N. Schmitt, J. Estaquier, F. Barre-Sinoussi, B. Hurtrel, R. Cheynier, and N. Israel. 2006. IL-7 induces immunological improvement in SIV-infected rhesus macaques under antiviral therapy. J. Immunol. 176: 914-922.
7. Audige, A., E. Schlaepfer, H. Joller, and R. F. Speck. 2005. Uncoupled anti-HIV and immune-enhancing effects when combining IFN-α and IL-7. J. Immunol. 175: 3724-3736.
8. Alpdogan, O., and M. R. van den Brink. 2005. IL-7 and IL-15: therapeutic cytokines for immunodeficiency. Trends Immunol. 26: 56-64.
9. Fry, T. J., M. Moniuszko, S. Creekmore, S. J. Donohue, D. C. Douek, S. Giardina, T. T. Hecht, B. J. Hill, K. Komschlies, J. Tomaszewski, G. Franchini, and C. L. Mackall. 2003. IL-7 therapy dramatically alters peripheral T-cell homeostasis in normal and SIV-infected nonhuman primates. Blood 101: 2294-2299.
10. Nugeyre, M. T., V. Monceaux, S. Beq, M. C. Cumont, R. Ho Tsong Fang, L. Chene, M. Morre, F. Barre-Sinoussi, B. Hurtrel, and N. Israel. 2003. IL-7 stimulates T cell renewal without increasing viral replication in simian immunodeficiency virus-infected macaques. J. Immunol. 171: 4447-4453.
11. Komschlies, K. L., K. J. Grzegorzewski, and R. H. Wiltrout. 1995. Diverse immunological and hematological effects of interleukin 7: implications for clinical application. J. Leukocyte Biol. 58: 623-633.
12. Watanabe, M., Y. Ueno, T. Yajima, Y. Iwao, M. Tsuchiya, H. Ishikawa, S. Aiso, T. Hibi, and H. Ishii. 1995. Interleukin 7 is produced by human intestinal epithelial cells and regulates the proliferation of intestinal mucosal lymphocytes. J. Clin. Invest. 95: 2945-2953.
13. Kroncke, R., H. Loppnow, H. D. Flad, and J. Gerdes. 1996. Human follicular dendritic cells and vascular cells produce interleukin-7: a potential role for interleukin-7 in the germinal center reaction. Eur. J. Immunol. 26: 2541-2544.
14. Napolitano, L. A., R. M. Grant, S. G. Deeks, D. Schmidt, S. C. De Rosa, L. A. Herzenberg, B. G. Herndier, J. Andersson, and J. M. McCune. 2001. Increased production of IL-7 accompanies HIV-1-mediated T-cell depletion: implications for T-cell homeostasis. Nat. Med. 7: 73-79.
15. Bolotin, E., G. Annett, R. Parkman, and K. Weinberg. 1999. Serum levels of IL-7 in bone marrow transplant recipients: relationship to clinical characteristics and lymphocyte count. Bone Marrow Transplant. 23: 783-788.
16. Fry, T. J., and C. L. Mackall. 2005. The many faces of IL-7: from lymphopoiesis to peripheral T cell maintenance. J. Immunol. 174: 6571-6576.
17. Park, J. H., Q. Yu, B. Erman, J. S. Appelbaum, D. Montoya-Durango, H. L. Grimes, and A. Singer. 2004. Suppression of IL7Rα transcription by IL-7 and other prosurvival cytokines: a novel mechanism for maximizing IL-7-dependent T cell survival. Immunity 21: 289-302.
18. Munitic, I., J. A. Williams, Y. Yang, B. Dong, P. J. Lucas, N. El Kassar, R. E. Gress, and J. D. Ashwell. 2004. Dynamic regulation of IL-7 receptor expression is required for normal thymopoiesis. Blood 104: 4165-4172.
19. Xue, H. H., P. E. Kovanen, C. A. Pise-Masison, M. Berg, M. F. Radovich, J. N. Brady, and W. J. Leonard. 2002. IL-2 negatively regulates IL-7 receptor α chain expression in activated T lymphocytes. Proc. Natl. Acad. Sci. USA 99: 13759-13764.
20. Lang, K. S., M. Recher, A. A. Navarini, N. L. Harris, M. Lohning, T. Junt, H. C. Probst, H. Hengartner, and R. M. Zinkemagel. 2005. Inverse correlation between IL-7 receptor expression and CD8 T cell exhaustion during persistent antigen stimulation. Eur. J. Immunol. 35: 738-745.
21. Kaech, S. M., J. T. Tan, E. J. Wherry, B. T. Konieczny, C. D. Surh, and R. Ahmed. 2003. Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat. Immunol. 4: 1191-1198.
22. + T-cell immune responses. Blood 107: 2855-2862.
23. Llano, A., J. Barretina, A. Gutierrez, J. Blanco, C. Cabrera, B. Clotet, and J. A. Este. 2001. Interleukin-7 in plasma correlates with CD4 T-cell depletion and may be associated with emergence of syncytium-inducing variants in human immunodeficiency virus type 1-positive individuals. J. Virol. 75: 10319-10325.
24. Rethi, B., C. Fluur, A. Atlas, M. Krzyzowska, F. Mowafi, S. Grutzmeier, A. De Milito, R. Bellocco, K. I. Falk, E. Rajnavolgyi, and F. Chiodi. 2005. Loss of IL-7Rα is associated with CD4 T-cell depletion, high interleukin-7 levels and CD28 down-regulation in HIV infected patients. AIDS 19: 2077-2086.
25. Sasson, S. C., J. J. Zaunders, G. Zanetti, E. M. King, K. M. Merlin, D. E. Smith, K. K. Stanley, D. A. Cooper, and A. D. Kelleher. 2006. Increased plasma interleukin-7 level correlates with decreased CD127 and increased CD132 extracellular expression on T cell subsets in patients with HIV-1 infection. J. Infect. Dis. 193: 505-514.
26. + T lymphocytes decreases with HIV disease progression and inversely correlates with immune activation. Eur. J. Immunol. 36: 336-344.
27. + T cells in HIV-infected individuals. J. Immunol. 174: 2900-2909.
28. + T cells is reduced in HIV infection and partially restored with effective antiretroviral therapy. J. Acquired Immune Defic. Syndr. 28: 454-457.
29. Colle, J. H., J. L. Moreau, A. Fontanet, O. Lambotte, M. Joussemet, S. Jacod, J. F. Delfraissy, and J. Theze. 2006. Regulatory dysfunction of the interleukin-7 receptor in CD4 and CD8 lymphocytes from HIV-infected patients-effects of antiretroviral therapy. J. Acquired Immune Defic. Syndr. 42: 277-285.
30. Marlink, R., P. Kanki, I. Thior, K. Travers, G. Eisen, T. Siby, I. Traore, C. C. Hsieh, M. C. Dia, E. H. Gueye, et al. 1994. Reduced rate of disease development after HIV-2 infection as compared to HIV-1. Science 265: 1587-1590.
31. Poulsen, A. G., P. Aaby, O. Larsen, H. Jensen, A. Naucler, I. M. Lisse, C. B. Christiansen, F. Dias, and M. Melbye. 1997. 9-year HIV-2-associated mortality in an urban community in Bissau, West Africa. Lancet 349: 911-914.
32. + cells is faster in HIV-1 than in HIV-2 infection. J. Acquired Immune Defic. Syndr. Hum. Retroviral. 16: 327-332.
33. Popper, S. J., A. D. Sarr, K. U. Travers, A. Gueye-Ndiaye, S. Mboup, M. E. Essex, and P. J. Kanki. 1999. Lower human immunodeficiency virus (HIV) type 2 viral load reflects the difference in pathogenicity of HIV-1 and HIV-2. J. Infect. Dis. 180: 1116-1121.
34. Sousa, A. E., J. Carneiro, M. Meier-Schellersheim, Z. Grossman, and R.-M. Victorino. 2002. CD4 T cell depletion is linked directly to immune activation in the pathogenesis of HIV-1 and HIV-2 but only indirectly to the viral load. J. Immunol. 169: 3400-3406.
35. + T-cell depletion in HIV infection: are we closer to understanding the cause. Nat. Med. 8: 319-323.
36. Popper, S. J., A. D. Sarr, A. Gueye-Ndiaye, S. Mboup, M. E. Essex, and P. J. Kanki. 2000. Low plasma human immunodeficiency virus type 2 viral load is independent of proviral load: low virus production in vivo. J. Virol. 74: 1554-1557.
37. Berry, N., K. Ariyoshi, S. Jaffar, S. Sabally, T. Corrah, R. Tedder, and H. Whittle. 1998. Low peripheral blood viral HIV-2 RNA in individuals with high CD4 percentage differentiates HIV-2 from HIV-1 infection. J. Hum. Virol. 1:457-468.
38. Sousa, A. E., A. F. Chaves, A. Loureiro, and R. M. Victorino. 2001. Comparison of the frequency of interleukin-2, interferon-g and interleukin-4 producing T cells in two diseases with distinct clinical outcomes: the human immunodeficiency virus type 1 and 2 Infections. J. Infect. Dis. 184: 552-559.
39. Marlink, R. 1996. Lessons from the second AIDS virus, HIV-2. AIDS 10: 689-699.
40. Whittle, H. C., K. Ariyoshi, and S. Rowland-Jones. 1998. HIV-2 and T cell recognition. Curr. Opin. Immunol. 10: 382-387.
41. Bock, P. J., and D. M. Markovitz. 2001. Infection with HIV-2. AIDS 15(Suppl. 5): S35-S45.
42. Soriano, V., P. Gomes, W. Heneine, A. Holguin, M. Doruana, R. Antunes, K. Mansinho, W. M. Switzer, C. Araujo, V. Shanmugam, et al. 2000. Human immunodeficiency virus type 2 (HIV-2) in Portugal: clinical spectrum, circulating subtypes, virus isolation, and plasma viral load. J. Med. Virol. 61: 111-116.
43. Andrew, D., and R. Aspinall. 2002. Age-associated thymic atrophy is linked to a decline in IL-7 production. Exp. Gerontol. 37: 455-463.
44. + T cell responses to influenza vaccine. J. Immunol. 173: 673-681.
45. Wang, F. X., Y. Xu, J. Sullivan, E. Souder, E. G. Argyris, E. A. Acheampong, J. Fisher, M. Sierra, M. M. Thomson, R. Najera, et al. 2005. IL-7 is a potent and proviral strain-specific inducer of latent HIV-1 cellular reservoirs of infected individuals on virally suppressive HAART. J. Clin. Invest. 115: 128-137.
46. Scripture-Adams, D. D., D. G. Brooks, Y. D. Korin, and J. A. Zack. 2002. Interleukin-7 induces expression of latent human immunodeficiency virus type 1 with minimal effects on T-cell phenotype. J. Virol. 76: 13077-13082.
47. Muthukumar, A., A. Wozniakowski, M. C. Gauduin, M. Paiardini, H. M. McClure, R. P. Johnson, G. Silvestri, and D. L. Sodora. 2004. Elevated interleukin-7 levels not sufficient to maintain T-cell homeostasis during simian immunodeficiency virus-induced disease progression. Blood 103: 973-979.
48. Gomes, P., N. C. Taveira, J. M. Pereira, F. Antunes, M. O. Ferreira, and M. H. Lourenco. 1999. Quantitation of human immunodeficiency virus type 2 DNA in peripheral blood mononuclear cells by using a quantitative-competitive PCR assay. J. Clin. Microbiol. 37: 453-456.
49. Damond, F., D. Descamps, I. Fartara, J. N. Telles, S. Puyeo, P. Campa, A. Lepretre, S. Matheron, F. Brun-Vezinet, and F. Simon. 2001. Quantification of proviral load of human immunodeficiency virus type 2 subtypes A and B using real-time PCR. J. Clin. Microbiol. 39: 4264-4268.
50. Kimmig, S., G. K. Przybylski, C. A. Schmidt, K. Laurisch, B. Mowes, A. Radbruch, and A. Thiel. 2002. Two subsets of naive T helper cells with distinct T cell receptor excision circle content in human adult peripheral blood. J. Exp. Med. 195: 789-794.
51. Rosok, B. I., L. Bostad, P. Voltersvik, R. Bjerknes, J. Olofsson, B. Asjo, and J. E. Brinchmann. 1996. Reduced CD4 cell counts in blood do not reflect CD4 cell depletion in tonsillar tissue in asymptomatic HIV-1 infection. AIDS 10: F35-F38.
52. Tenner-Racz, K., H. J. Stellbrink, J. van Lunzen, C. Schneider, J. P. Jacobs, B. Raschdorff, G. Grosschupff, R. M. Steinman, and P. Racz. 1998. The unenlarged lymph nodes of HIV-1-infected, asymptomatic patients with high CD4 T cell counts are sites for virus replication and CD4 T cell proliferation: the impact of highly active antiretroviral therapy. J. Exp. Med. 187: 949-959.
53. + T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J. Exp. Med. 200: 749-759.
54. + T lymphocytes from effector sites in the gastrointestinal tract. J. Exp. Med. 200: 761-770.
55. Grossman, Z., M. Meier-Schellersheim, W. E. Paul, and L. J. Picker. 2006. Pathogenesis of HIV infection: what the virus spares is as important as what it destroys. Nat. Med. 12: 289-295.
56. + T cells in HIV-2 infection. J. Virol. 80: 12425-12429.
57. Managua, E. Z., A. Landay, and L. Al-Harthi. 2006. Interleukin-7 induces HIV replication in primary naive T cells through a nuclear factor of activated T cell (NFAT)-dependent pathway. Virology 350: 443-452.
58. Kopka, J., D. Mecikovsky, P. C. Aulicino, A. M. Mangano, C. A. Rocco, R. Bologna, and L. Sen. 2005. High IL-7 plasma levels may induce and predict the emergence of HIV-1 virulent strains in pediatric infection. J. Clin. Virol. 33: 237-242.
59. Frech, K., R. Brack-Werner, and T. Werner. 1996. Common modular structure of lentivirus LTRs. Virology 224: 256-267.